Ivermectin is not approved for treatment of COVID-19 in Japan, and the U.S.
Food & Drug Administration, the World Health Organization, the EU drug regulator and Merck
(MRK.N), which makes the drug, have warned against its use because of a lack of scientific evidence that it has therapeutic effect.
read more
In guidance on its website dated September 2021, the FDA noted growing interest in the drug for preventing or treating COVID-19 in humans but said it had received multiple reports of patients who had required medical attention, including hospitalisation, after self-medicating with it.
The use of ivermectin to treat COVID-19 is currently being investigated in a UK trial run by the University of Oxford. The researchers said on Monday that it was still under way and they did not want to comment further until they have results to report.
read more
Many potential COVID-19 treatments that showed promise in test tubes, including the antimalarial hydroxychloroquine promoted by former U.S. President Donald Trump, ultimately failed to show benefit for COVID-19 patients once studied in clinical trials.
www.sorryantivaxxer.com
floridapolitics.com
